Leqembi Archives | TheCable

--Advertisement--

Follow

Follow

Eisai, the drugs lead developer, will market lecanemab under the name Lequembi, with a price tag of 26,500 dollars a year. (Photo: Eisai)

Eisai, the drugs lead developer, will market lecanemab under the name Lequembi, with a price tag of 26,500 dollars a year. (Photo: Eisai)

US approves use of new drug which ‘slows progression of Alzheimer’s disease’

January 8, 2023

error: Content is protected from copying.